Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Researchers from Swansea University Medical School and the College of Human and Health Sciences have used electronic medical records (EMRs) to improve clinical trials by expanding remote monitoring. Findings were published May 16 in Scientific Reports.
Researchers from the University of Waterloo in Ontario, Canada, have developed artificial intelligence (AI) capable of using wearable-collected data to predict the onset of health problems. Findings were published Feb. 23 in the Journal of Applied Physiology.
Mobile health (mHealth) applications are seen as useful tools by physicians treating women with gestational diabetes mellitus (GDM), according to a study published May 14 in JMIR mHealth and uHealth.
A judge in Riverside County, California, ruled the state legislature violated the law by passing the state’s aid-in-dying act during a special session limited to healthcare funding, giving the state’s attorney general five days to respond or else it would again be illegal for terminal patients to be given life-ending drugs by physicians.
Teledermatology for suspected skin cancer costs more than usual care—but it speeds up the time to clinical resolution by nearly a month, according to a study published online May 9 in JAMA Dermatology.
Consumer sleep technologies like wearables and mobile apps are adept at collecting patient-generated health data, but lacking validation data and FDA clearance are hindering utilization, according to a position statement published in the May 15 issue of the Journal of Clinical Sleep Medicine.
The “zero year” of the OneCare Vermont system, operated much like an accountable care organization (ACO) on a statewide level, saw the program come within 1 percent of its financial target. With the model now expanded to cover about 18 percent of the state’s residents, other states are watching closely to see if it could be implemented elsewhere in the U.S.
